Evidence map›Paper›PMID 36698764›Full record

ArticleBioinformatics advances2023

Computational analyses reveal fundamental properties of the AT structure related to thrombosis.

Tiago J S Lopes, Ricardo A Rios, Tatiane N Rios, Brenno M Alencar, Marcos V Ferreira, Eriko Morishita

Open access · goldAbstract read
In one paragraph

Article in Bioinformatics advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tiago J S LopesCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo 157-8535, Japan.ORCID https://orcid.org/0000-0001-9605-5177
Ricardo A RiosInstitute of Computing, Federal University of Bahia, Salvador 40170-110, Brazil.
Tatiane N RiosInstitute of Computing, Federal University of Bahia, Salvador 40170-110, Brazil.
Brenno M AlencarInstitute of Computing, Federal University of Bahia, Salvador 40170-110, Brazil.
Marcos V FerreiraInstitute of Computing, Federal University of Bahia, Salvador 40170-110, Brazil.
Eriko MorishitaDepartment of Clinical Laboratory Science, Division of Health Sciences, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan.
Universidade Federal da Bahia · BRKanazawa University · JPNational Center For Child Health and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: Blood coagulation is a vital process for humans and other species. Following an injury to a blood vessel, a cascade of molecular signals is transmitted, inhibiting and activating more than a dozen coagulation factors and resulting in the formation of a fibrin clot that ceases the bleeding. In this process, antithrombin (AT), encoded by the SERPINC1 gene is a key player regulating the clotting activity and ensuring that it stops at the right time. In this sense, mutations to this factor often result in thrombosis-the excessive coagulation that leads to the potentially fatal formation of blood clots that obstruct veins. Although this process is well known, it is still unclear why even single residue substitutions to AT lead to drastically different phenotypes. In this study, to understand the effect of mutations throughout the AT structure, we created a detailed network map of this protein, where each node is an amino acid, and two amino acids are connected if they are in close proximity in the three-dimensional structure. With this simple and intuitive representation and a machine-learning framework trained using genetic information from more than 130 patients, we found that different types of thrombosis have emerging patterns that are readily identifiable. Together, these results demonstrate how clinical features, genetic data and Supplementary information: Supplementary data are available at

Identifiers

PMID36698764
PMCPMC9838315
OpenAlexW4312116533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.